172 related articles for article (PubMed ID: 10427142)
1. Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.
Laupeze B; Amiot L; Courtois A; Vernhet L; Drenou B; Fauchet R; Fardel O
Int J Oncol; 1999 Sep; 15(3):571-6. PubMed ID: 10427142
[TBL] [Abstract][Full Text] [Related]
2. Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486.
Payen L; Delugin L; Courtois A; Trinquart Y; Guillouzo A; Fardel O
Biochem Biophys Res Commun; 1999 May; 258(3):513-8. PubMed ID: 10329417
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
4. The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells.
Payen L; Delugin L; Courtois A; Trinquart Y; Guillouzo A; Fardel O
Br J Pharmacol; 2001 Feb; 132(3):778-84. PubMed ID: 11159731
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
[TBL] [Abstract][Full Text] [Related]
6. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells.
Courtois A; Payen L; Vernhet L; de Vries EG; Guillouzo A; Fardel O
Cancer Lett; 1999 May; 139(1):97-104. PubMed ID: 10408915
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Essodaigui M; Broxterman HJ; Garnier-Suillerot A
Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
[TBL] [Abstract][Full Text] [Related]
9. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion.
Feller N; Broxterman HJ; Währer DC; Pinedo HM
FEBS Lett; 1995 Jul; 368(2):385-8. PubMed ID: 7628644
[TBL] [Abstract][Full Text] [Related]
10. The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells.
Payen L; Courtois A; Vernhet L; Guillouzo A; Fardel O
Int J Cancer; 1999 May; 81(3):479-85. PubMed ID: 10209965
[TBL] [Abstract][Full Text] [Related]
11. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
13. Both P-gp and MRP contribute to drug resistance in AML.
Legrand O; Simonin G; Zittoun R; Marie JP
Leukemia; 1998 Aug; 12(8):1327-8. PubMed ID: 9697893
[No Abstract] [Full Text] [Related]
14. Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells.
Vernhet L; Courtois A; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
FEBS Lett; 1999 Jan; 443(3):321-5. PubMed ID: 10025956
[TBL] [Abstract][Full Text] [Related]
15. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metals.
Vernhet L; Allain N; Bardiau C; Anger JP; Fardel O
Toxicology; 2000 Jan; 142(2):127-34. PubMed ID: 10685512
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood.
Laupèze B; Amiot L; Payen L; Drénou B; Grosset JM; Lehne G; Fauchet R; Fardel O
Life Sci; 2001 Feb; 68(11):1323-31. PubMed ID: 11233999
[TBL] [Abstract][Full Text] [Related]
19. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.
Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP
Blood; 1998 Jun; 91(12):4480-8. PubMed ID: 9616142
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
